Optimal Use of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Patients Undergoing Percutaneous Coronary Interventions

Receptor Antagonists ◽

Coronary Interventions ◽

Medical Decision Making with Incomplete Evidence—Choosing a Platelet Glycoprotein IIbIIIa Receptor Inhibitor for Percutaneous Coronary Interventions

Medical Decision Making ◽

10.1177/0272989x05275156 ◽

2005 ◽

Vol 25 (2) ◽

pp. 222-228 ◽

Cited By ~ 5

Author(s):

James M. Brophy ◽

Lawrence Joseph

Keyword(s):

Decision Making ◽

Medical Decision Making ◽

Medical Decision ◽

Platelet Glycoprotein ◽

Coronary Interventions ◽

Percutaneous Coronary ◽

Receptor Inhibitor

Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions

The American Journal of Cardiology ◽

10.1016/s0002-9149(03)00816-6 ◽

2003 ◽

Vol 92 (6) ◽

pp. 651-655 ◽

Cited By ~ 74

Author(s):

David F Kong ◽

Vic Hasselblad ◽

Robert A Harrington ◽

Harvey D White ◽

James E Tcheng ◽

...

Keyword(s):

Meta Analysis ◽

Platelet Glycoprotein ◽

Coronary Interventions ◽

Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions

ACC Current Journal Review ◽

10.1016/s1062-1458(03)00080-1 ◽

2003 ◽

Vol 12 (2) ◽

pp. 81

Author(s):

E. Karvouni ◽

D.G. Katritsis ◽

J.P.A. Ioannidis

Keyword(s):

Receptor Antagonists ◽

Coronary Interventions ◽

P2856 Cumulative meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions

European Heart Journal ◽

10.1016/s0195-668x(03)95634-x ◽

2003 ◽

Vol 24 (5) ◽

pp. 544

Author(s):

D KONG

Keyword(s):

Meta Analysis ◽

Platelet Glycoprotein ◽

Coronary Interventions ◽

Effect of intravenous glycoprotein IIb/IIIa receptor antagonists on survival in percutaneous coronary interventions: A meta-analysis

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(03)80192-4 ◽

2003 ◽

Vol 41 (6) ◽

pp. 45

Author(s):

Evangelia Karvouni ◽

Demosthenes G. Katritsis ◽

John P. Ioannidis

Keyword(s):

Meta Analysis ◽

Receptor Antagonists ◽

Coronary Interventions ◽

Assessment of use of Glycoprotein IIb/IIIa receptor antagonists in patients undergoing percutaneous coronary interventions

Journal of Molecular and Cellular Cardiology ◽

10.1016/j.yjmcc.2006.06.053 ◽

2006 ◽

Vol 41 (4) ◽

pp. 746-746

Author(s):

K.J. Shah ◽

K.H. Parikh ◽

M.C. Chag ◽

U.G. Shah ◽

A.H. Chandarana ◽

...

Keyword(s):

Receptor Antagonists ◽

Coronary Interventions ◽

Analysis of Number Needed to Treat and Cost of Platelet Glycoprotein IIb/IIIa Inhibitors in Percutaneous Coronary Interventions and Acute Coronary Syndromes

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1592/phco.19.13.1086.31592 ◽

1999 ◽

Vol 19 (9) ◽

pp. 1086-1093 ◽

Cited By ~ 5

Author(s):

Dawn M. Bell

Keyword(s):

Acute Coronary Syndromes ◽

Platelet Glycoprotein ◽

Number Needed To Treat ◽

Coronary Interventions ◽

Percutaneous Coronary ◽

Coronary Syndromes

Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(02)02666-9 ◽

2003 ◽

Vol 41 (1) ◽

pp. 26-32 ◽

Cited By ~ 124

Author(s):

Evangelia Karvouni ◽

Demosthenes G Katritsis ◽

John P.A Ioannidis

Keyword(s):

Receptor Antagonists ◽

Coronary Interventions ◽

The dark side of platelet glycoprotein IIb/IIIa receptor inhibitors during percutaneous coronary interventions

The American Journal of Cardiology ◽

10.1016/s0002-9149(03)00267-4 ◽

2003 ◽

Vol 91 (10) ◽

pp. 1199-1202 ◽

Cited By ~ 2

Author(s):

Lloyd W. Klein ◽

James E. Calvin

Keyword(s):

Dark Side ◽

Platelet Glycoprotein ◽

Coronary Interventions ◽

Effect of intravenous glycoprotein IIb/IIIa receptor antagonists on survival in percutaneous coronary interventions: a meta-analysis

Cardiovascular Revascularization Medicine ◽

10.1016/j.carrev.2006.03.011 ◽

2006 ◽

Vol 7 (2) ◽

pp. 84-85

Author(s):

F. Aslam

Keyword(s):

Meta Analysis ◽

Receptor Antagonists ◽

Coronary Interventions ◽